Bill > A1014

Introduced Session

This bill establishes the Kidney Disease Prevention and Education Task Force. The purpose of this task force is to: 1) develop and implement a public awareness campaign about the benefits of the early detection and treatment of kidney disease that includes, but is not limited to, health education programs, preventative screenings, and social media, television, and radio outreach; (2) examine racial disparities in the rates of chronic kidney disease, kidney transplantations, and living and deceased kidney donations and identify opportunities to promote health equity; and (3) make recommendations in the implementation of a cost-effective plan for early screening, diagnosis, and treatment of chronic kidney disease Statewide. The task force will consist of 11 members as follows: one member of the General Assembly, appointed by the Speaker of the General Assembly, who shall serve as co-chairperson; one member of the General Assembly, appointed by the Assembly Minority Leader; one member of the Senate, appointed by the President of the Senate, who shall serve as co-chairperson; one member of the Senate, appointed by the Senate Minority Leader; the Commissioner of Health or the commissioner's designee, who shall serve ex officio; the Director of the Office of Minority and Multicultural Health or the director's designee, who shall serve ex officio; and five public members, who will be appointed by the Governor, that include: one nephrologist; one primary care physician; one member who is a pharmaceutical representative that works with existing kidney medication; one member who is a representative from a leading dialysis center; and one member who has chronic kidney disease between Stages 2-4 that is healthy enough to participate and is not already in one of the previous membership categories listed. The task force will present a report of its findings and recommendations to the Governor to the Legislature no later than two years after the organization of the task force. The task force will expire 30 days after the issuance of its report.

AI Summary

Committee Categories

Balvir Singh (D)*,  Anthony Verrelli (D), 

Introduced, Referred to Assembly Health Committee (on 01/13/2026)

Official Document